Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kirsch

Showing results (331-340 of 376) with videos related to

Pageof 38
Sort By:
Blood|December 1, 1987
Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint regionE Lipford, J J Wright, W Urba, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosisTian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
ACS Chemical Neuroscience|July 9, 2014
Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosisPaul C Trippier, Kevin Tianmeng Zhao, Susan G Fox, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS"Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2010
Generation after generation: exploring the psychological impact of providing genetic services through a cascading approachDonald W Hadley, Sato Ashida, Jean F Jenkins, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 21, 2007
Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counselingJean Jenkins, Kathleen A Calzone, Eileen Dimond, et al.
The Journal of Clinical Investigation|September 26, 2017
Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing αβ T cell clonesTiago R Matos, John T O'Malley, Elizabeth L Lowry, et al.
Oncology Reports|May 5, 2005
A phase II and pharmacologic study of fluorouracil given by a 1-hour infusion daily for 5 days with leucovorin and interferon alpha-2a in adenocarcinoma of the large bowelAbdel Salam Attia Ismail, Mary G Quinn, Maurice A Wright, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2020
Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant <i>Staphylococcus aureus</i> to β-Lactam AntibioticsYongliang Fang, Jack R Kirsch, Liang Li, et al.
Science Advances|September 12, 2020
Globally deimmunized lysostaphin evades human immune surveillance and enables highly efficacious repeat dosingHongliang Zhao, Seth A Brooks, Susan Eszterhas, et al.
Pageof 38

Showing results (331-340 of 376) with videos related to

Sort By:
Pageof 38
Blood|December 1, 1987
Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint regionE Lipford, J J Wright, W Urba, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosisTian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
ACS Chemical Neuroscience|July 9, 2014
Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosisPaul C Trippier, Kevin Tianmeng Zhao, Susan G Fox, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS"Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2010
Generation after generation: exploring the psychological impact of providing genetic services through a cascading approachDonald W Hadley, Sato Ashida, Jean F Jenkins, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 21, 2007
Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counselingJean Jenkins, Kathleen A Calzone, Eileen Dimond, et al.
The Journal of Clinical Investigation|September 26, 2017
Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing αβ T cell clonesTiago R Matos, John T O'Malley, Elizabeth L Lowry, et al.
Oncology Reports|May 5, 2005
A phase II and pharmacologic study of fluorouracil given by a 1-hour infusion daily for 5 days with leucovorin and interferon alpha-2a in adenocarcinoma of the large bowelAbdel Salam Attia Ismail, Mary G Quinn, Maurice A Wright, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2020
Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant <i>Staphylococcus aureus</i> to β-Lactam AntibioticsYongliang Fang, Jack R Kirsch, Liang Li, et al.
Science Advances|September 12, 2020
Globally deimmunized lysostaphin evades human immune surveillance and enables highly efficacious repeat dosingHongliang Zhao, Seth A Brooks, Susan Eszterhas, et al.
Pageof 38